Roquefort Therapeutics (ROQ) Stock Chart & Stock Price History GBX 1.56 -0.09 (-5.15%) As of 11:12 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Roquefort Therapeutics Stock Price Performance 5 Day Performance-5.15%1 Month Performance-17.02%3 Month Performance-61.83%6 Month Performance-55.29%Year-To-Date Performance-61.83%1 Year Performance-77.64% Receive ROQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ROQ Stock Chart for Tuesday, April, 1, 2025 ROQ Chart by TradingViewRemove Ads Roquefort Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/31/2025GBX 1.67GBX 1.60-3.72%GBX 1.70GBX 1.601.95 million shs£2.04 million03/28/2025GBX 1.65GBX 1.67+0.91%GBX 1.68GBX 1.652.00 million shs£2.12 million03/27/2025GBX 1.70GBX 1.65-2.83%GBX 1.95GBX 1.602.46 million shs£2.10 million03/26/2025GBX 1.87GBX 1.70-8.95%GBX 1.90GBX 1.6022.01 million shs£2.16 million03/25/2025GBX 1.88GBX 1.87-0.85%GBX 1.92GBX 1.8018.82 million shs£2.37 million03/24/2025GBX 1.93GBX 1.88-2.69%GBX 2.16GBX 1.803.25 million shs£2.39 million03/21/2025GBX 2.06GBX 1.93-6.17%GBX 2.30GBX 1.931.22 million shs£2.46 million03/20/2025GBX 2.10GBX 2.06-1.90%GBX 2.30GBX 1.904.45 million shs£2.62 million03/19/2025GBX 2.13GBX 2.10-1.55%GBX 2.30GBX 1.909.94 million shs£2.67 million03/18/2025GBX 2.40GBX 2.13-11.13%GBX 2.80GBX 2.059.14 million shs£2.71 million Get the Latest News and Ratings for ROQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/17/2025GBX 1.80GBX 2.40+33.04%GBX 2.50GBX 216.26 million shs£3.05 million03/14/2025GBX 1.56GBX 1.80+15.94%GBX 1.95GBX 1.6011.57 million shs£2.30 million03/13/2025GBX 1.80GBX 1.56-13.56%GBX 1.90GBX 1.5011.29 million shs£1.98 million03/12/2025GBX 1.95GBX 1.80-7.55%GBX 2.50GBX 1.8010.89 million shs£2.29 million03/11/2025GBX 2.35GBX 1.95-17.08%GBX 2.37GBX 1.8023.05 million shs£2.48 million03/10/2025GBX 1.52GBX 2.35+54.98%GBX 3GBX 1.9032.57 million shs£2.99 million03/07/2025GBX 1.52GBX 1.52GBX 1.62GBX 1.52305,131 shs£1.93 million03/06/2025GBX 1.63GBX 1.52-6.77%GBX 1.52GBX 1.4011,915 shs£1.93 million03/05/2025GBX 1.65GBX 1.63-1.52%GBX 1.65GBX 1.6320,000 shs£2.07 million03/04/2025GBX 1.60GBX 1.65+3.12%GBX 1.81GBX 1.502.02 million shs£2.10 million03/03/2025GBX 1.89GBX 1.60-15.16%GBX 1.80GBX 1.486.20 million shs£2.04 million02/28/2025GBX 1.60GBX 1.89+17.88%GBX 1.90GBX 1.625.97 million shs£2.40 million Related Companies OBD Stock Price Chart SNG Stock Price Chart IXI Stock Price Chart CIZ Stock Price Chart FAB Stock Price Chart HEMO Stock Price Chart APTA Stock Price Chart GENF Stock Price Chart VAL Stock Price Chart BSFA Stock Price Chart Receive ROQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:ROQ) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
